Ikena Oncology Inc Share Price

NASDAQ: IKNA

$1.43

+0.06

(+4.38%)

as on July 26, 2025 at 1:29 am IST

$₹

The stock has been delisted from the stock exchange on 25 Jul 2025

Ikena Oncology Inc Stock Performance

as on July 26, 2025 at 1:29 am IST

$1.43
Day's Price Range
$1.43
$1.43
52 Week's Low
52 Week's High
$11.65
52-Week Price Range
$23.28
$1.43
-714.57%
Downside
1527.97%
Upside

Ikena Oncology Inc share price movements today

Previous Close: $1.37
Open: $1.43
Volume: 101.0
Day's Low - High: $1.43 - $1.43
52 Week Low - High: $11.65 - $23.28

Ikena Oncology Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Ikena Oncology Inc Stock Fundamentals & Key Indicators

Check Ikena Oncology Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Ikena Oncology Inc stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Ikena Oncology Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Ikena Oncology Inc	BUY	$-	NA	NA	0.00%

Analyst Recommendation on Ikena Oncology Inc Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Ikena Oncology Inc. Average target price of $23

Ikena Oncology Inc Share Price Target

Get share price movements and forecasts by analysts on Ikena Oncology Inc.

What analysts predicted

93.78%UPSIDE

Target Price

$23

Current Price

$1.43

Analyzed by

11 Analysts

Target

$23.00

Ikena Oncology Inc target price $23, a slight upside of 93.78% compared to current price of $1.43. According to 11 analysts rating.

Ikena Oncology Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	5	2	1	0	-	-	-	-	-	-
Gross Profit	5	1	0	0	0	0	-	-	-	-
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-14	-17	-17	-19	-16	-13	-10	-9	-8	-2
Net Profit Margin	-267.63%	-854.04%	-1463.54%	-2957.36%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Ikena Oncology Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	13	9	30	15	9	-
Gross Profit	-37	-11	-35	-16	13	8	-
Operating Income	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-
Net Income	-40	-16	-44	-34	-66	-68	-49
Net Profit Margin	-4127.78%	-122.28%	-481.36%	-110.10%	-426.60%	-744.17%	0.00%

Global Institutional Holdings in Ikena Oncology Inc

Funds	Holdings
Blue Owl Capital Holdings LP	8.48%
Bvf Inc	8.3%
BML Capital Management LLC	7.69%
Orbimed Advisors, LLC	7.33%
Deep Track Capital, LP	5.21%

See all

Insights on Ikena Oncology Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 7 quarters, -19.48M → -2.76M (in $), with an average increase of 50.3% per quarter
POSITIVE IMPACT
Price Rise
In the last 7 days, IKNA stock has moved up by 12.6%
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 79.3% return, outperforming this stock by 95.2%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 66.7% return, outperforming this stock by 138.4%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 6 quarters, 6.40M → 659.0K (in $), with an average decrease of 33.0% per quarter

About Ikena Oncology Inc

Ikena Oncology, Inc. is a clinical-stage, targeted oncology company. The Company is focused on developing differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance. Its lead program in the RAS pathway, IK-595, is a molecular glue designed to trap MEK and RAF in an inactive complex, more completely inhibiting RAS signals than existing inhibitors. IK-595’s ability to complex the RAFs, including CRAF prevents a signaling bypass mechanism that cancer cells employ to drive therapeutic resistance to other drugs in this class. IK-595 is being developed as an oral therapy and evaluated in a Phase I clinical trial in RAS and RAF mutant cancers.

Organisation	Ikena Oncology Inc
E-voting on shares	Click here to vote

FAQs

What is Ikena Oncology Inc share price today?

Ikena Oncology Inc share price today is $1.43 as on July 26, 2025 at 1:29 am IST at the close of the market. Ikena Oncology Inc share today touched a day high of $1.43 and a low of $1.43.

What is the 52 week high and 52 week low for Ikena Oncology Inc share?

Ikena Oncology Inc share touched a 52 week high of $23.28 on December 23, 2024 and a 52 week low of $11.65 on April 9, 2025. Ikena Oncology Inc stock price today i.e. July 26, 2025 at 1:29 am IST is closed at $1.43,which is 93.86% down from its 52 week high and -87.72% up from its 52 week low.

How to invest in Ikena Oncology Inc Stock (IKNA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Ikena Oncology Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ikena Oncology Inc Shares that will get you 1.0490 shares as per Ikena Oncology Inc share price of $1.43 per share as on July 26, 2025 at 1:29 am IST.

What is the minimum amount required to buy Ikena Oncology Inc Stock (IKNA) from India?

Indian investors can start investing in Ikena Oncology Inc (IKNA) shares with as little as ₹88.25 or $1 (as of September 13, 2025 at 3:51 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.50 in Ikena Oncology Inc stock (as per the Rupee-Dollar exchange rate as on September 13, 2025 at 3:51 am IST). Based on Ikena Oncology Inc share’s latest price of $1.43 as on July 26, 2025 at 1:29 am IST, you will get 6.9930 shares of Ikena Oncology Inc. Learn more about fractional shares .